Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes.
Derakhshankhah H, Sajadimajd S, Jahanshahi F, Samsonchi Z, Karimi H, Hajizadeh-Saffar E, Jafari S, Razmi M, Malvajerd SS, Bahrami G, Razavi M, Izadi Z.
Derakhshankhah H, et al. Among authors: karimi h.
Tissue Eng Part B Rev. 2022 Oct;28(5):1053-1066. doi: 10.1089/ten.TEB.2021.0134. Epub 2022 Apr 4.
Tissue Eng Part B Rev. 2022.
PMID: 34696626
Review.